drugset / Trial / NCT00605410
Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness
Phase 4
Completed
12 enrolled
University of Saskatchewan
Royal University Hospital Foundation · collab
RandomizedCrossoverTriple-blindDiagnostic
Summary
Certain lung disease medications can influence diagnostic tests and research investigations. This study will investigate how long ipratropium bromide must be withheld before a methacholine challenge test can be conducted. This information will be useful for validating current guidelines.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ipratropium | Small molecule | 40 ug | Inhaled |